Strong, silent and stigmatized
Sports & Exercise Medicine Switzerland · 2020
DOI: 10.34045/sems/2020/28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sports & Exercise Medicine Switzerland, 2020.
Abstract (Originalsprache)
The global lifetime prevalence rate of all image and performance enhancing drugs (IPED) is unknown, however it is 6.4% in men an 1.6% in women for anabolic androgenic steroids [1]. IPED are widely used in the bodybuilding scene and have found a bigger audience through social media platforms. Risk groups for IPED use are young men, leisure athletes, general gym goers, elite athletes and bodybuilders. The main drivers for IPED use are increased muscularity and performance. Abuse of performance enhancing drugs in elite sports (doping) is well recognized, however IPED abuse is a public health problem that is often overlooked and should be addressed by the medical community.
Zitieren
APA
(2020). Strong, silent and stigmatized. Sports & Exercise Medicine Switzerland. https://doi.org/10.34045/sems/2020/28
Vancouver
Strong, silent and stigmatized. Sports & Exercise Medicine Switzerland. 2020. doi:10.34045/sems/2020/28
BibTeX
@article{euvimed2020,
title = {Strong, silent and stigmatized},
journal = {Sports & Exercise Medicine Switzerland},
year = {2020},
doi = {10.34045/sems/2020/28}
}
EUVIMED